Jia (Jenny) Liu, Translational Researcher at The Kinghorn Cancer Centre, shared a post on X:
“Congratulations Herbert Loong and team on the AACR25 oral and simultaneous publication Nature Medicine of D3S-001 next gen G12C inhibitor in KRASm -phase 1 trial!
Great excuse to celebrate with whilst in Chicago!”
Herbert Loong, Chair-Elect of the International Affairs Committee and the Track Leader for Sarcoma (2023) at the American Society of Clinical Oncology (ASCO), reshared the post on X, adding:
“Thanks Jia (Jenny) Liu! Amazing food and conversations indeed!
Looking forward to welcoming you to Hong Kong for ESMO – Eur. Oncology ESMOTATAsia25 in July when we can continue our culinary excursions.”
More posts featuring Herbert Loong.
